BONDRONAT conc perf 6 mg/6ml flac 6 ml
7680574240014
CH-57424
M05BA06
07.99.0.
Reimbursement limitations:
BONDRONAT3
Remboursement pour les patientes souffrant de métastases osseuses dues à un cancer du sein.
1 / 3
google
Details
- Product number
- 5742401
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- acidum ibandronicum 6.0 mg ut natrii ibandronas monohydricus, natrii chloridum, acidum aceticum glaciale, natrii acetas trihydricus, aqua ad iniectabile q.s. ad solutionem pro 6 ml corresp. natrium 20.94 mg.
Articles (1)
Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
6.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
20.94 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 210.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2006
Authorization holder
Atnahs Pharma Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 57424
- Drug name
- Bondronat 6 mg/6 ml, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- M05BA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 25/10/2005
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BONDRONAT conc perf 6 mg/6ml flac 6 ml
- Description (DE)
- BONDRONAT Inf Konz 6 mg/6ml Durchstf 6 ml
- Market launch
- 25/10/2005
- Narcotic (BTM)
- No